Literature DB >> 14652743

4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi.

Shailja Misra-Bhattacharya1, Diksha Katiyar, Preeti Bajpai, R P Tripathi, J K Saxena.   

Abstract

A compound of the coumarin class, 4-methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one, was evaluated for antifilarial activity against the human filarial parasite, Brugia malayi (sub-periodic strain) in Mastomys coucha. The test compound brought about a 24.4% reduction in circulating microfilaremia on day 8 after initiation of treatment when administered by the peritoneal route at a dose of 50 mg/kg for 5 consecutive days. The compound also caused a 62.0% mortality in adult parasites. Apart from killing adult filariids, it also brought about sterilization of 81.8% of the surviving female B. malayi. An oral dose of 200 mg/kg for 5 consecutive days was less effective (35.5% adulticidal efficacy and 65.8% sterilization). In vitro, the compound killed adult B. malayi at 100 microM concentration and inhibited DNA topoisomerase II activity in the filarial parasite. Studies are in progress using the compound in combination with standard antifilarials as well as other active agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14652743     DOI: 10.1007/s00436-003-1014-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

1.  Antifilarial activity of some 2H-1-benzopyran-2-ones (coumarins).

Authors:  R P Tripathi; R Tripathi; A P Bhaduri; S N Singh; R K Chatterjee; P K Murthy
Journal:  Acta Trop       Date:  2000-09-18       Impact factor: 3.112

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Development of in vitro screening system for assessment of antifilarial activity of compounds.

Authors:  M Mukherjee; S Misra; R K Chatterjee
Journal:  Acta Trop       Date:  1998-07-30       Impact factor: 3.112

4.  Optimization of test conditions for development of MTT as in vitro screen.

Authors:  M Mukherjee; S Misra; R K Chatterjee
Journal:  Indian J Exp Biol       Date:  1997-01       Impact factor: 0.818

5.  The response to Litomosoides carinii to antifilarial agents in cotton rat (Sigmodon hispidus) & multimammate rat (Mastomys natalensis).

Authors:  S Misra; R K Chatterjee; A B Sen
Journal:  Indian J Med Res       Date:  1984-06       Impact factor: 2.375

Review 6.  Strategies and tools for the control/elimination of lymphatic filariasis.

Authors:  E A Ottesen; B O Duke; M Karam; K Behbehani
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

  6 in total
  10 in total

1.  Search for new prototypes for the chemotherapy of filariasis: a chemotherapeutic and biochemical approach.

Authors:  Preeti Bajpai; Shailendra Kumar Verma; Diksha Katiyar; Neetu Tewari; R P Tripathi; Iti Bansal; J K Saxena; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2005-03-01       Impact factor: 2.289

2.  Molecular characterization of an rsmD-like rRNA methyltransferase from the Wolbachia endosymbiont of Brugia malayi and antifilarial activity of specific inhibitors of the enzyme.

Authors:  Ajay Kumar Rana; Sharat Chandra; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

3.  Chemical constituents and antifilarial activity of Lantana camara against human lymphatic filariid Brugia malayi and rodent filariid Acanthocheilonema viteae maintained in rodent hosts.

Authors:  Namita Misra; Mithilesh Sharma; Kanwal Raj; Anil Dangi; Sudhir Srivastava; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2006-10-24       Impact factor: 2.289

4.  Antifilarial activity of caffeic acid phenethyl ester on Brugia pahangi in vitro and in vivo.

Authors:  Nazeh M Al-Abd; Zurainee Mohamed Nor; Quazim O Junaid; Marzida Mansor; M S Hasan; Mustafa Kassim
Journal:  Pathog Glob Health       Date:  2017-10-25       Impact factor: 2.894

5.  Gedunin and photogedunin of Xylocarpus granatum possess antifilarial activity against human lymphatic filarial parasite Brugia malayi in experimental rodent host.

Authors:  Sweta Misra; Meenakshi Verma; Sunil Kumar Mishra; Shishir Srivastava; Vijai Lakshmi; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2011-04-27       Impact factor: 2.289

6.  The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae.

Authors:  V Lakshmi; R Kumar; P Gupta; V Varshney; M N Srivastava; M Dikshit; P K Murthy; S Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2004-07-09       Impact factor: 2.289

Review 7.  Current drug targets for helminthic diseases.

Authors:  Ajay Kumar Rana; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2013-03-26       Impact factor: 2.289

8.  In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick), against human lymphatic filarial parasite Brugia malayi: antifilarial activity of H. exigua.

Authors:  Vijai Lakshmi; Shishir Srivastava; Sunil Kumar Mishra; Sweta Misra; Meenakshi Verma; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2009-07-22       Impact factor: 2.289

9.  Prior killing of intracellular bacteria Wolbachia reduces inflammatory reactions and improves antifilarial efficacy of diethylcarbamazine in rodent model of Brugia malayi.

Authors:  Shilpy Shakya; Preeti Bajpai; Sharad Sharma; Shailja Misra-Bhattacharya
Journal:  Parasitol Res       Date:  2008-01-08       Impact factor: 2.289

10.  In vitro gene silencing of independent phosphoglycerate mutase (iPGM) in the filarial parasite Brugia malayi.

Authors:  Prashant Kumar Singh; Susheela Kushwaha; Shahab Mohd; Manisha Pathak; Shailja Misra-Bhattacharya
Journal:  Infect Dis Poverty       Date:  2013-03-25       Impact factor: 4.520

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.